The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.

pbmcapply: Tracking the Progress of Mc*pply with Progress Bar

A light-weight package helps you track and visualize the progress of parallel version of vectorized R functions (mc*apply). Parallelization (mc.core > 1) works only on *nix (Linux, Unix such as macOS) system due to the lack of fork() functionality, which is essential for mc*apply, on Windows.

Version: 1.5.1
Depends: utils, parallel
Published: 2022-04-28
DOI: 10.32614/CRAN.package.pbmcapply
Author: Kevin Kuang (aut), Quyu Kong (ctb), Francesco Napolitano (ctb)
Maintainer: Kevin kuang <kvn.kuang at mail.utoronto.ca>
BugReports: https://github.com/kvnkuang/pbmcapply/issues
License: MIT + file LICENSE
URL: https://github.com/kvnkuang/pbmcapply
NeedsCompilation: yes
CRAN checks: pbmcapply results

Documentation:

Reference manual: pbmcapply.pdf

Downloads:

Package source: pbmcapply_1.5.1.tar.gz
Windows binaries: r-devel: pbmcapply_1.5.1.zip, r-release: pbmcapply_1.5.1.zip, r-oldrel: pbmcapply_1.5.1.zip
macOS binaries: r-release (arm64): pbmcapply_1.5.1.tgz, r-oldrel (arm64): pbmcapply_1.5.1.tgz, r-release (x86_64): pbmcapply_1.5.1.tgz, r-oldrel (x86_64): pbmcapply_1.5.1.tgz
Old sources: pbmcapply archive

Reverse dependencies:

Reverse imports: adaptDiag, ASpli, boot.heterogeneity, CAISEr, CALANGO, fastpos, fungible, gemini, ghypernet, glmmSeq, GREMLINS, mappp, mvMORPH, navigation, opdisDownsampling, quickPWCR, RAINBOWR, ROSeq, sccore, scDesign3, scSpatialSIM, seqsetvis, SignacX, sobolnp, SP2000, spatialTIME, streetscape, vesselr, viewscape, WhatIf
Reverse suggests: HelpersMG, imagefluency, progressr, robber, tidybulk

Linking:

Please use the canonical form https://CRAN.R-project.org/package=pbmcapply to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.